PURPOSE: To compare signal penetration depth and deep structure-visualization of swept source (SS) and spectral domain (SD)-optical coherence tomography (OCT) with and without enhanced depth imaging (EDI) and B-scan averaging modes. METHODS: Volume scans were obtained from 20 eyes of healthy volunteers by DRI OCT-1, Spectralis using EDI and B-scan averaging, and Cirrus HD-OCT. The signal penetration depth was measured as the distance between the retinal pigment epithelium and the deepest visible anatomical structure at the foveal center. Visibility and contrast of the choroidoscleral junction and of vascular details within the choroid were assessed across the entire volume using an ordinal scoring scale. Outcome measures were compared using paired t-test and rank-sum test. RESULTS: The mean signal penetration depth was 498±114 μm for Spectralis, 491±85 μm for DRI OCT-1, and 123±65 μm for Cirrus; P=0.9708 Spectralis vs DRI OCT-1, P<0.0001 Spectralis vs Cirrus, and P<0.0001 DRI OCT-1 vs Cirrus. Mean ranks for visibility and contrast of the choroidoscleral junction were 3.83 for Spectralis, 3.98 for DRI OCT-1, and 2.00 for Cirrus; and 3.45 for Spectralis, 2.93 for DRI OCT-1, and 1.58 for Cirrus. Mean ranks for visibility and contrast of vascular details were 3.73 (Spectralis), 3.70 (DRI OCT-1), and 2.23 (Cirrus); and 3.53 (Spectralis), 2.05 (DRI OCT-1), and 1.98 (Cirrus). CONCLUSION: Signal penetration depths are similar for SS-OCT and SD-OCT using EDI and frame averaging, and statistically significantly lower without EDI/averaging. Both SD-OCT using EDI/frame averaging and SS-OCT offer excellent visualization capabilities for volumetric imaging of the choroidoscleral interface.
PURPOSE: To compare signal penetration depth and deep structure-visualization of swept source (SS) and spectral domain (SD)-optical coherence tomography (OCT) with and without enhanced depth imaging (EDI) and B-scan averaging modes. METHODS: Volume scans were obtained from 20 eyes of healthy volunteers by DRI OCT-1, Spectralis using EDI and B-scan averaging, and Cirrus HD-OCT. The signal penetration depth was measured as the distance between the retinal pigment epithelium and the deepest visible anatomical structure at the foveal center. Visibility and contrast of the choroidoscleral junction and of vascular details within the choroid were assessed across the entire volume using an ordinal scoring scale. Outcome measures were compared using paired t-test and rank-sum test. RESULTS: The mean signal penetration depth was 498±114 μm for Spectralis, 491±85 μm for DRI OCT-1, and 123±65 μm for Cirrus; P=0.9708 Spectralis vs DRI OCT-1, P<0.0001 Spectralis vs Cirrus, and P<0.0001 DRI OCT-1 vs Cirrus. Mean ranks for visibility and contrast of the choroidoscleral junction were 3.83 for Spectralis, 3.98 for DRI OCT-1, and 2.00 for Cirrus; and 3.45 for Spectralis, 2.93 for DRI OCT-1, and 1.58 for Cirrus. Mean ranks for visibility and contrast of vascular details were 3.73 (Spectralis), 3.70 (DRI OCT-1), and 2.23 (Cirrus); and 3.53 (Spectralis), 2.05 (DRI OCT-1), and 1.98 (Cirrus). CONCLUSION: Signal penetration depths are similar for SS-OCT and SD-OCT using EDI and frame averaging, and statistically significantly lower without EDI/averaging. Both SD-OCT using EDI/frame averaging and SS-OCT offer excellent visualization capabilities for volumetric imaging of the choroidoscleral interface.
Authors: Sergio Copete; Ignacio Flores-Moreno; Javier A Montero; Jay S Duker; José M Ruiz-Moreno Journal: Br J Ophthalmol Date: 2013-11-28 Impact factor: 4.638
Authors: D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito Journal: Science Date: 1991-11-22 Impact factor: 47.728
Authors: Mehreen Adhi; Jonathan J Liu; Ahmed H Qavi; Ireneusz Grulkowski; Chen D Lu; Kathrin J Mohler; Daniela Ferrara; Martin F Kraus; Caroline R Baumal; Andre J Witkin; Nadia K Waheed; Joachim Hornegger; James G Fujimoto; Jay S Duker Journal: Am J Ophthalmol Date: 2014-02-18 Impact factor: 5.258
Authors: Li Zhang; Kyungmoo Lee; Meindert Niemeijer; Robert F Mullins; Milan Sonka; Michael D Abràmoff Journal: Invest Ophthalmol Vis Sci Date: 2012-11-01 Impact factor: 4.799
Authors: Kathrin J Mohler; Wolfgang Draxinger; Thomas Klein; Jan Philip Kolb; Wolfgang Wieser; Christos Haritoglou; Anselm Kampik; James G Fujimoto; Aljoscha S Neubauer; Robert Huber; Armin Wolf Journal: Invest Ophthalmol Vis Sci Date: 2015-10 Impact factor: 4.799
Authors: Iwona Gorczynska; Justin V Migacz; Robert J Zawadzki; Arlie G Capps; John S Werner Journal: Biomed Opt Express Date: 2016-02-19 Impact factor: 3.732
Authors: Francisco de Asís Bartol-Puyal; Carlos Isanta; Óscar Ruiz-Moreno; Beatriz Abadia; Pilar Calvo; Luis Pablo Journal: J Ophthalmol Date: 2019-08-15 Impact factor: 1.909
Authors: Chun On Lee; Xiujuan Zhang; Nan Yuan; Shumin Tang; Li Jia Chen; Carol Y Cheung; Jason C Yam Journal: Sci Rep Date: 2021-07-02 Impact factor: 4.379